UroGen Pharma (URGN) PT Raised to $30 at Guggenheim
Tweet Send to a Friend
(Updated - June 13, 2025 7:16 AM EDT)
Guggenheim analyst Kelsey Goodwin raised the price target on UroGen Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Kelsey Goodwin raised the price target on UroGen Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


